Florida’s New Guidance on Psychotropic Medication for Children
As attorneys, we have represented people whose freedom was at stake in mental health facilities, challenged unlawful Baker Act detentions, and litigated cases involving serious abuse inside those facilities. So when Florida issues statewide guidance about the psychiatric treatment of children, our first question isn’t whether we agree with the medical recommendation.
Our question is: what does this actually mean for the families who have to make these decisions?
On July 24, 2026, the Florida Department of Health issued new guidance addressing psychotropic medications for children ages 5 to 17. For parents of a child taking medication for ADHD, anxiety, depression, or another mental health condition, the headlines alone can raise some frightening questions.
- Do we need to change our child’s medication?
- Can a doctor still prescribe it?
- What happens if two parents disagree?
- Does this affect what happens during a mental health crisis?
Those are very different questions, and they shouldn’t be lumped together.
First and most importantly: if your child is currently taking a psychotropic medication, do not stop it or change the dose because of an article, a headline, or the state’s guidance. Some medications can cause serious effects when stopped abruptly. Questions about changing treatment should be addressed with the health care professional who knows your child and prescribed the medication.
Here is what we think Florida families need to understand.
What Florida is recommending
The Department of Health’s guidance addresses psychotropic medications, including treatments for anxiety, depression, ADHD, and behavioral disorders, in children ages 5 to 17. State officials have acknowledged that these medications can be clinically appropriate and medically necessary. The guidance advocates a more cautious approach, citing concerns about insufficient initial evaluations, limited long-term safety data, and off-label pediatric use.
Three core recommendations:
Comprehensive evaluations:
Providers are encouraged to conduct thorough assessments that look beyond presenting symptoms to medical history, mental health, sleep, screen time, physical activity, diet, and contributing environmental factors, and to consider laboratory testing for underlying medical conditions.
Non-pharmacological first steps:
Where clinically appropriate, non-medication interventions such as psychotherapy and behavioral therapy should be explored before prescribing.
Careful tapering:
Where a provider determines that reducing or discontinuing a medication is appropriate, the guidance recommends tapering gradually under medical supervision rather than stopping abruptly.
The guidance applies except in emergencies.
What the guidance does not do
Headlines about state policy can cause a great deal of unnecessary alarm. On this one, the distinctions matter.
It is not a law. Florida has not passed legislation banning psychotropic medications for children. The Department of Health issued medical guidance, not a statute, and it does not invalidate existing prescriptions.
Medical judgment remains intact. Physicians and psychiatrists retain their full legal and clinical authority to exercise independent medical judgment.
Your current treatment plan stands. The state has not ordered families to alter or discontinue established care plans. If your child is doing well on their current regimen, this guidance is not a reason to make independent changes.
How to use this information
While the guidance changes nothing automatically, it can be a useful prompt for conversations with your child’s care team. Questions worth asking:
- Why was this specific medication recommended?
- What non-medication alternatives were considered before prescribing?
- How is the current medication helping, and what should we be monitoring?
- If a change or discontinuation is eventually recommended, what is the clinical reasoning and the safe protocol for doing it?
Not everyone in the medical community agrees
The guidance follows a broader federal push and has drawn criticism from parts of the professional community.
Responding to a related federal position earlier in 2026, the American Academy of Child and Adolescent Psychiatry said it challenged established psychiatric diagnoses and evidence-based treatments too broadly and imprecisely, and warned that doing so creates risk for children and families. The organization has urged that decisions affecting access to psychiatric medication be informed by child and adolescent psychiatrists and other qualified clinicians.
We raise this because parents deserve to know that this is an area of active professional disagreement rather than settled consensus, and because your child’s provider may hold a different view than the Department of Health. We take no position on the clinical question. It isn’t ours to take.
Doctors decide what is clinically appropriate. The law determines what people and institutions are permitted to do.
After working with families through Baker Act cases and other mental health crises, this is the distinction we wish families didn’t have to learn in the middle of an emergency.
We are attorneys, not physicians. We do not advise on whether a specific medication is right for your child. That decision belongs to your family and your child’s doctors.
Our work begins when the question shifts from what is clinically appropriate to who has the authority to decide, and whether an institution has stayed within what the law permits.
Florida’s guidance influences medical recommendations. When a situation involves parental rights, involuntary treatment, or detention, the law sets the boundaries.
Where these questions become legal ones
-
Parents who disagree:
For separated or divorced parents, this guidance does not resolve disputes about psychiatric medication. Whether medical decision-making authority is shared or held by one parent depends on your parenting plan and on Florida family law. -
Involuntary examination under the Baker Act:
When a child is held for involuntary examination, specific legal criteria apply, along with rules governing timelines, receiving facility conduct, and patient rights. Families in that situation often need immediate clarity about what a facility is obligated to do and what decision-making authority they still hold. Our Baker Act practice handles these matters. -
Facility accountability:
Admission to a psychiatric facility does not give a hospital unlimited authority. Florida law protects patients against overreach and mistreatment, and we have litigated serious facility abuse cases. -
Co-occurring substance use:
Mental health crises sometimes overlap with substance use, which brings Florida’s Marchman Act into play. The two systems operate under separate legal standards.
What this will mean for most families
For most families, this guidance will not create a legal emergency. Its effect will show up in routine medical visits.
Providers may ask more detailed questions about sleep, diet, screen time, physical activity, and home life. Non-medication options may be suggested before starting medication or alongside existing treatment. Some physicians may want to reassess an active prescription to discuss progress, dosage, or tapering.
None of that reduces your authority as a parent. You retain the right to speak up if you’re concerned about changing a treatment plan that’s working, to ask why a particular medication or therapy is being recommended, and to seek a second opinion.
If your child is in crisis
If your child is in immediate danger or experiencing a mental health emergency:
- Call 911 for urgent local help.
- Call or text 988 for the free, 24/7 Suicide and Crisis Lifeline.
Read the source directly
Rather than relying on headlines or social media summaries, we’d encourage parents to read the state’s guidance themselves.
Talk to us
We don’t interfere with medical decisions that belong between families and their doctors. But no parent should be sitting outside a facility wondering who is looking out for their child’s rights.
If Florida’s guidance or a facility’s actions have raised questions about parental decision-making authority, your child’s legal or patient rights, or a situation involving the Baker Act or Marchman Act, contact our office to discuss your family’s situation confidentially, or call 904-600-4384.
This article is provided for general informational purposes only. It is legal information, not legal advice, and it is not medical advice. Nothing here should be used to make decisions about a child’s medical treatment. Reading this article does not create an attorney-client relationship. Questions about your child’s medication should be directed to the prescribing provider. Every case is different, and past results do not guarantee a similar outcome in any future matter.
